Antimicrobial, antiadhesive, and antibiofilm actions of rhamnolipids on ESKAPE pathogens

Lett Appl Microbiol. 2023 Feb 16;76(2):ovad013. doi: 10.1093/lambio/ovad013.

Abstract

The aim of this study was to test the antimicrobial, antiadhesive, and antibiofilm activities of a rhamnolipid extracted from Pseudomonas aeruginosa UKMP14T previously isolated from oil-contaminated soil in Malaysia against ESKAPE (i.e. multidrug resistant) pathogens. Zones of inhibition in an agar well diffusion assay were observed at 50 µg mL-1 concentrations of rhamnolipid for all the ESKAPE bacteria. The MIC and MBC values ranged between 7.81-62.5 µg mL-1 and 31.25-1000 µg mL-1, respectively. Percent killing was recorded to be >90% except for Klebsiella pneumoniae (86.84%). Furthermore, antiadhesion studies showed that there was 76% hindrance in attachment of Enterococcus faecium and 91% in Acinetobacter baumannii at 4 × MIC. The highest inhibition in adhesion was found at 4 × MIC, which was 46% for Ac. baumannii and 62% for Enterococcus faecium. Finally, the antibiofilm capability of the rhamnolipid was determined, which ranged between 25%-76% in Ac. baumannii and 35%-88% in Enterococcus faecium. To the best of our knowledge, this is the first study to include research on antimicrobial, antiadhesive and antibiofilm activities of rhamnolipid from the local isolate Ps. aeruginosa UKMP14T against ESKAPE bacteria. Obtained results suggest that this rhamnolipid can be exploited commercially for the production of novel antibiotics.

Keywords: Pseudomonas aeruginosa UKMP14T; ESKAPE; antiadhesive; antibiofilm; antimicrobial; biosurfactant; rhamnolipid.

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Bacteria
  • Biofilms
  • Glycolipids*
  • Klebsiella pneumoniae

Substances

  • rhamnolipid
  • Anti-Bacterial Agents
  • Glycolipids